To ensure multi-stakeholder input, an Advisory Group is installed and re-installed every year. This Advisory Group consists of carefully selected key opinion leaders representing the different stakeholders (clinicians, data custodians, researchers, regulatory decision-makers, people with MS/patient societies, and industry).
The composition can change over time and is reselected every year, but reflects the ecosystem to a sufficient extent so that the Advisory Group can act as a circle of trust in defining the MSDA’s strategy.
The Advisory Group is the key scientific steering body of the MSDA, crucial to raise the voice of the stakeholders in providing strategic as well as scientific advice on the MSDA mission, vision, activities, governance principles and values.
The members of the MSDA Advisory Group of 2022 are:
|Hernandez Martinez De Lapiscina||Elena|